DuPont is executing a rapid commercialization strategy in its Applied BioSciences business for a diverse portfolio of high-performance, renewable products that address the needs of large markets. Thee company has set goals for the Applied BioSciences business of US$1 billion in revenue and US$250 million in pretax earnings by 2015.
For more details on Growing demand drives global commercialization for DuPont Renewable Products click here
Tuesday, May 18, 2010
Growing demand drives global commercialization for DuPont Renewable Products
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment